Although early studies have emphasized the significant role of AR in ccRCC tumour growth, tumor metastasis and angiogenesis [22, 25–27], no evidence link its contribution to pazopanib resistance. The gene discussed is AR; the disease is nonpapillary renal cell carcinoma.